simvastatin has been researched along with Bone Loss, Perimenopausal in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (80.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, T; Makino, K; Otsuka, M; Takemasa, M | 1 |
| Cui, Y; Fu, X; Guo, Q; Leng, H; Ma, T; Song, C; Tan, J; Yang, N; Yin, X | 1 |
| Campagna, MS; Cepollaro, C; Franci, MB; Gennari, C; Gonnelli, S; Lucani, B; Montagnani, A; Pacini, S | 1 |
| Cobellis, L; De Leo, V; la Marca, A; Lanzetta, D; Morgante, G; Petraglia, F | 1 |
| Andreasen, F; Buus, NH; Heickendorff, L; Larsen, ML; Mosekilde, L; Rejnmark, L; Vestergaard, P | 1 |
| Gümüşer, G; Taneli, F; Tikiz, C; Tikiz, H; Tüzün, C | 1 |
| Galus, K | 1 |
| Borgström, F; Jönsson, B; Kanis, JA; Ström, O; Zethraeus, N | 1 |
| Soska, V; Soucek, M; Svejda, P | 1 |
| Meunier, PJ | 1 |
2 review(s) available for simvastatin and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
[Prevention and treatment of osteoporosis].
Topics: Absorptiometry, Photon; Anticholesteremic Agents; Bone Density; Bone Density Conservation Agents; Calcitonin; Calcium, Dietary; Diphosphonates; Female; Fractures, Bone; Health Behavior; Health Knowledge, Attitudes, Practice; Humans; Male; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Selective Estrogen Receptor Modulators; Simvastatin; Sodium Fluoride; Strontium; Vitamin D | 2005 |
Anabolic agents for treating postmenopausal osteoporosis.
Topics: Animals; Controlled Clinical Trials as Topic; Female; Fluorides; Fractures, Spontaneous; Growth Hormone; Humans; Insulin-Like Growth Factor I; Organometallic Compounds; Osteoporosis, Postmenopausal; Parathyroid Hormone; Simvastatin; Thiophenes | 2001 |
3 trial(s) available for simvastatin and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women.
Topics: Aged; Alkaline Phosphatase; Anticholesteremic Agents; Biomarkers; Body Composition; Body Weight; Bone and Bones; Bone Density; Bone Remodeling; Cholesterol; Collagen; Collagen Type I; Double-Blind Method; Female; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Longitudinal Studies; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Peptides; Simvastatin; Triglycerides | 2004 |
Effects of simvastatin on bone mineral density and remodeling parameters in postmenopausal osteopenic subjects: 1-year follow-up study.
Topics: Adult; Aged; Alkaline Phosphatase; Bone and Bones; Bone Density; Bone Remodeling; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Simvastatin | 2005 |
[The impact of statin therapy on bone density changes in postmenopausal women].
Topics: Aged; Bone Density; Bone Remodeling; Cardiovascular Diseases; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Osteoporosis, Postmenopausal; Simvastatin | 2007 |
5 other study(ies) available for simvastatin and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Preparation of calcium phosphate nanocapsules including simvastatin/deoxycholic acid assembly, and their therapeutic effect in osteoporosis model mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone and Bones; Bone Density Conservation Agents; Calcium Phosphates; Cell Line; Deoxycholic Acid; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Female; Humans; Hypolipidemic Agents; Mice; Mice, Inbred Strains; Micelles; Nanocapsules; Osteoporosis, Postmenopausal; Random Allocation; Simvastatin; Surface Properties; Surface-Active Agents | 2013 |
Single-dose local simvastatin injection improves implant fixation via increased angiogenesis and bone formation in an ovariectomized rat model.
Topics: Absorptiometry, Photon; Animals; Blood Vessels; Bone Density; Bone Morphogenetic Protein 2; Bone Screws; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Femur; Gene Expression Regulation; Humans; Injections, Intralesional; Neovascularization, Physiologic; Osseointegration; Osteogenesis; Osteoporosis, Postmenopausal; Ovariectomy; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley; Simvastatin; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; von Willebrand Factor | 2015 |
Effect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic postmenopausal women: a 1-year longitudinal study.
Topics: Aged; Alkaline Phosphatase; Anticholesteremic Agents; Bone Density; Bone Remodeling; Collagen; Collagen Type I; Female; Humans; Hypercholesterolemia; Middle Aged; Osteoporosis, Postmenopausal; Peptides; Simvastatin; Time Factors | 2003 |
Combination of statins and hormone replacement therapy in postmenopausal women is associated with increased bone mineral density.
Topics: Absorptiometry, Photon; Bone Density; Bone Remodeling; Estrogen Replacement Therapy; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Osteoporosis, Postmenopausal; Pravastatin; Retrospective Studies; Simvastatin | 2003 |
The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden.
Topics: Aged; Aged, 80 and over; Alendronate; Antihypertensive Agents; Bone Density Conservation Agents; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Middle Aged; Models, Econometric; Osteoporosis, Postmenopausal; Quality-Adjusted Life Years; Simvastatin; Sweden | 2008 |